SECsense Logo

Sonnet Biotherapeutics Holdings, Inc. 8-K Report: Key Updates & Insights

$SONN
Form 8-K
Filed on: 2024-12-17
Source
Sonnet Biotherapeutics Holdings, Inc. 8-K Report: Key Updates & Insights

Based on the provided section of the financial report, here are the key pieces of information and insights extracted:

Entity Information

  • Company Name: Sonnet Biotherapeutics Holdings, Inc.
  • CIK: 0001106838
  • SEC Filing Type: 8-K
  • Filing Date: December 17, 2024
  • State of Incorporation: Delaware (DE)
  • IRS Employer Identification Number (EIN): 20-2932652
  • Address: 100 Overlook Center, Suite 102, Princeton, NJ 08540
  • Contact Phone: (609) 375-2227

Stock Information

  • Stock Symbol: SONN
  • Exchange: NASDAQ
  • Common Stock Par Value: $0.0001

Reporting Period

  • Reporting Period Start Date: December 17, 2024
  • Reporting Period End Date: December 17, 2024

Units of Measurement

  • Currency: US Dollars (USD)
  • Shares Measurement: Shares

Insights

  • The report is a Form 8-K, which typically indicates that the company is reporting on a significant event. This could include various corporate actions, financial performance updates, or other material events that warrant disclosure.
  • The presence of XBRL (eXtensible Business Reporting Language) indicates that the filings are structured to facilitate data extraction and analysis, reflecting a commitment to transparency and compliance with SEC regulations.
  • The filing date coincides with the reporting period, suggesting that this might be a real-time update concerning a specific event or decision made by the company on that date.

Conclusion

This financial report highlights the basic details concerning Sonnet Biotherapeutics Holdings, Inc., including its SEC filing, stock information, and contact details. The use of XBRL and the 8-K filing type suggests that the company is actively maintaining regulatory compliance and transparency with its stakeholders.